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Evaluation of patients with epilepsy: an outpatient 
clinic based study 
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CEYHAN, NURCAN S(3NMEZ, BELGiN (3NGEL, VEDAT S(DZMEN & BULENT GOKKUS. 
Baktrk5y State Hospital for Neurological and Psychiatric Diseases, Neurology Department, "lstanbul, 
Turkey 
In order to identify the demographic features, seizure types and epilepsies, we reviewed the files of 1379 patients 
admitted to the epilepsy outpatient clinic of Baklrkt~y State Hospital for Neurological and Psychiatric Diseases 
between 1991 and 1994. Of these, 160 patients' files contained inadequate information and 80 patients with 
nonepileptic events were excluded from the study. There were 523 female and 616 male patients ranging in age 
from 6 months to 87 years. Risk factors could be identified in 612 (54.3%) of patients. Some 62.1% of patients had 
partial and 34.8% had generalized seizures, whilst 71.0% were classified as partial and 11.9% as generalized 
epilepsies. Two per cent were classed as special syndromes and 15% as undetermined. In our series the unclassified 
cases represented 3.1% of the total. We discuss the results and compared them with other studies. 
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INTRODUCTION 
Epilepsy can be regarded as a diverse collection 
of clinical syndromes presenting with characteris- 
tic seizures as a consequence of abnormal 
synchronization and amplification of neuronal 
firing in electrically unstable area of the brain 1. 
Epilepsy is a disease creating not only medical 
but a lot of social problems as well. Its chronic 
nature and long-term treatment usually give rise 
to marital, educational, vocational and legal 
problems. Worldwide prevalence of epilepsy is 
0.5-1% 2 . In our country it is estimated as 0.7%, 
1.02% and 0.93% in three studies conducted in 
different parts of Turkey 3-5. 
It is one of the major neurological disorders in 
developing countries. In certain regions the 
prevalence rates are as high as ten times the 
average of those in developed countries 6 but the 
comparison of studies is difficult as there are only 
a few publications from developing countries 
which used ICES 896-7 . 
Lack of accurate data on epileptic patients 
prevents a rational approach to the problems. To 
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identify the characteristics of the patient popula- 
tion at our epilepsy outpatient clinic, we carried 
out this retrospective study in our hospital. 
PATIENTS AND METHODS 
We reviewed the files of 1379 patients admitted to 
the epilepsy outpatient clinic of Bak~rkSy State 
Hospital for Neurological and Psychiatric 
Diseases between January 1991 and March 1994. 
Our hospital, with 100 beds for neurology and 
2000 beds for psychiatry, not only serves people 
living in Istanbul but all over Turkey. Our patient 
population therefore consists of people living in 
both urban and rural areas. All patients were 
recorded according to a standard protocol by 
trained residents or specialists. One hundred and 
sixty patients with inadequate information and 80 
patients with nonepileptic attacks were excluded 
from the study. The patients were evaluated 
according to their age, age at onset of seizures, 
risk factors, EEG and imaging study results and 
antiepileptic drugs they use currently. All cases 
are classified according to the classification 
proposed by ILAE for seizure ICES 19818 and 
epilepsies and epileptic syndromes ICE 19899 . 
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RESULTS 
700 
Eighty patients were excluded from the study 
because of non-epileptic attacks as follows: 64 
with psychogenic seizures, 9 with syncope, 5 with 
breath holding spells, 1 with cataplexy and 1 
patient with startle. 
We evaluated 1139 patients with epileptic 
seizures. There were 523 females (45.9%) and 616 
males (54.1%). Age distribution ranged from 6 
months to 87 years (mean 29.1 years). 
We grouped all patients according to their age 
at admission (Fig. 1) and age at onset (Fig. 2). 
We classified the seizures in our patient group 
according to the ILAE Classification of Seizures 
1981 to dominant seizure type (Table 1). The 
classification of patients according to ILAE 
Classification of Epilepsies and Epileptic Syn- 
dromes 1989 is given in Table 2. 
Possible risk factors could be identified in 612 
(54.3%) patients. These are shown in Table 3. 
Of the 978 (85%) patients who underwent one 
or more surface EEG examinations, abnormal 
traces were reported in 612 (62%). In 199 patients 
(20.3%) this abnormality was focal spike and 
wave activity, in 106 patients (10.8%) focal slow 
wave, in 165 (16.9%) generalized spike and wave 
and in 142 (14.5%) generalized slow wave 
activity. 
One or more abnormalities were demonstrated 
in 230 of 531 patients (56.7%) who had under- 
gone a computerized tomographic (CT) scan 
(Table 4). Seventy-five patients underwent mag- 
netic resonance imaging (MRI) and it was 
abnormal in 39 of them (50.7%) (Table 5). 
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Fig. 1. Distribution of patients according to age at 
admission. 
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Fig. 2. Distribution of patients according to age at onset. 
The distribution of patients according to their 
currently prescribed antiepileptic drug is shown in 
Table 6. 
DISCUSSION 
The distribution of patients as a function of age at 
admission is similar to the studies reported by 
Senaneyeke 6 and Tobias t, who studied agroup of 
adult patients imilar to that presented in this 
study, but is different o the group studied by 
Danesi 7who found that patients younger than 15 
years comprise 51.5% of the whole patient 
population. As shown in Fig. 1, most of our 
patients were admitted between the age of 20 and 
59, but when we take into account he onset of 
seizures, the number of cases before age 12 and 
between the age of 20 and 59 were nearly similar 
(Fig. 2). The frequency of patients with classifi- 
able seizures in our study (96.8%) is one of the 
highest reported. In some studies from develop- 
Table 1: Classification of patients according to ILAE 
classification of seizures (1981) to dominant seizure type 
Classification n % 
Partial seizures (PS) 708 62.1 
Simple PS 88 7.7 
Complex PS 288 25.2 
Secondary generalized 332 29. l 
Generalized seizures 396 34.7 
Absence 18 1.5 
Tonic 12 1.05 
Atonic 20 1.75 
Myoclonic 40 3.5 
Tonic-clonic 306 26.8 
Unclassified 35 3.01 
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Table 2: The classification of patients according to ILAE 
classification of epilepsies and epileptic syndromes 1989 
Classification n % 
Partial Syndromes 909 71,02 
Idiopathic 24 2.11 
Symptomatic 476 41.79 
Cryptogenic 299 26.25 
Generalized Syndromes 136 11.94 
Idiopathic 
Juvenile Absence 10 0.88 
Juvenile myoclonic 30 2.63 
Childhood Absence 10 0.88 
Generalized tonic-clonic on 
awakening 2 0.17 
Epilepsies with seizures 
precipitated by specific mode of 
activation 7 0.61 
Other generalized i iopathic 
epilepsies not defined above 62 5.44 
Cryptogenic/symptomatic 
West Syndrome 2 0.17 
Lennox-Gastaut syndrome 5 0.43 
Epilepsies with myoclonic-astatic 
seizures 1 0.08 
Symptomatic 
Specific syndromes 7 0.61 
Undetermined 171 15.01 
Epilepsies with both generalized 
and focal features: Other 
undetermined epilepsies not 
defined above 59 5.18 
Epilepsies without unequivocal 
generalized or focal features 112 9.8 
Special Syndromes 23 2.01 
ing countries it varies from 81% ~° to 96.3% 7, 
whereas some of the studies in developed 
countries record figures as low as 71.5% t~ or as 
high as 91.8% 12 . Most of these studies were 
published before the adoption of 1981 ICES and 
the variations in results probably reflect the 
different methods used in classification. Two 
studies which adopted ICES 1981 reported 
82.5%13 and 97.1%6 for classifiable cases. 
Partial seizures (PS, 62.1%) are twice as 
common as generalized seizures (34.76%) in our 
study. In developing countries the frequency of 
PS recorded as low as  54.5% 14 or  57% 15 and as 
Table 3: Risk factors that could be identified 
Factor n % 
Head trauma 181 15.87 
Febrile seizures 123 10.7 
Birth injuries 101 8.86 
CNS infections 80 7.02 
Family history 54 4.74 
CVD 21 1.84 
Brain tumour 25 2.2 
Alcohol abuse 21 1.84 
CVD, cerebro vascular disease; CNS, central nervous ystem. 
Table 4: Abnormalities identified by CT scan 
Abnormality n 
111 
Brain tumour 25 
Intracerebral haematoma 6 
Infarct 55 
Hemiatrophy 7 
Porencephaly 7 
Arteriovenous malformation 3 
Cranial fracture 5 
Encephalomalasie 9 
Arachnoid cyst 10 
Calcification 1 
Hydrocephalus 6 
Asymmetry of lateral ventricule 7 
Dilatation of temporal horn 4 
Atrophy in various regions 32 
Periventicular hypodensity 2 
Venous hemangioma 1 
Agenesis of corpus callosum 5 
Lipoma on corpus callosum 1 
Total 230 
high as 73.8% 6 or 76.6%. 7In developed countries 
the frequency of PS varies from a high of 66% ~2-16 
to lows of 45% I~ and 33% 17. The predominance 
of PS in developing countries could reflect the 
high incidence of symptomatic epilepsy in these 
countries resulting from cortical damage owing to 
secondary factors such as infection, birth injury 
and head trauma. 
The frequency of complex partial seizures 
(CPS, 25.2%) and simple partial seizures (SPS, 
7.7%) was lower than that of secondary 
generalized partial seizures (SGPS, 29.1%). The 
distribution of these seizures is variable. When we 
compare the frequency of CPS in Turkey with 
developing countries it is higher than studies 
reported by Senaneyike 6 (8.8%), Joshi 1° (13%) 
and lower than Osuntokun Is (51.4%) and Danesi 7
Table 5: Abnormalities identified on MRI' 
Abnormality n 
Mesial temporal sclerosis 7 
Heterotopia 1 
Encephalomalasie 2 
Arachnoid cyst 5 
Venous angiom 1 
Porencephaly 1 
Cavernoma 1 
Hemiatrophy 2 
Atrophy 4 
Hydrocephalus 3 
Hypophysis adenoma 3 
Multiple sclerosis 1 
Infection 3 
Brain tumour 2 
Hypoplasia of temporal lobe 1 
Agenesis of corpus callosum 2 
Total 39 
112 
Table 6: Antiepileptic drugs at referral 
Drug n % 
Carbamazepine 459 40 
Phenytoin 220 19.3 
Phenobarbital 56 4.9 
Valproic acid 81 7. I 
Clonazepam 15 1.6 
Barbexoclone 109 9.5 
Ethosuccimide 2 0.1 
Multiple 193 17.0 
(35.7%). Figures from developed countries from 
Alving ~2, 39.6%, and Gastout jl, 55.9%, showed 
higher frequencies than ours. Using different 
diagnostic riteria for categorization may explain 
the difference among these series. On the other 
hand without a videomonitoring system it is very 
difficult to identify the focal beginning of SGPS. 
Previous investigators complained of the same 
difficulties 13-6 and this fact was underlined in 
Shorvon's review '9. We classified our patients 
under the SGPS category if we could identify any 
focal feature with EEG and/or imaging 
techniques. The classification of epileptic seizure 
type is essential to choose the specific medication 
for a particular seizure type, but consideration of
seizure type is not adequate. Classification of 
epilepsy and epileptic syndromes i more useful 
for proper diagnosis and helps to predict the 
prognosis and treatment. It is also important for 
the rationalization of the therapy. According to 
our epilepsy classification, 71.02% of seizures 
were partial and 11.94% were generalized. 
Idiopathic partial epilepsies (IPE) comprised 
2.11% of these. This figure can be explained by 
the presence in the study group of a small number 
of patients of paediatric age in which we 
encountered IPE more often. In generalized 
epilepsies (GE), juvenile myoclonic epilepsy 
formed an important category (2.63%). This 
agrees with previous eries reported by Danesi 7
2%, Alving '2 0.8% and Gastout ~' 3.7%. 
Childhood absence epilepsies are rare with 
frequencies between 1 and 6%. 2J9 Our figure of 
0.88% is concordant with studies from developing 
countries. 
Risk factors were identified according to the 
history given by the patient or the family. When 
we compared our results with the other studies, 
the most common aetiological factor was head 
trauma s in an Indian study I°, whilst in England ~ 
and Sri Lanka 6 it takes third place. Our second 
most common aetiological factor is febrile 
seizures which is the most common factor in 
reports from Sri Lanka 6 and Nigeria 7. In third 
place is birth injury which is surprisingly less 
(~. Ozkara et al 
common than in England' and higher than in 
India '°, Nigeria v and Sri Lanka ~. The reason for 
these unexpectedly small figures from these 
developing countries may be lack of adequate 
information. 
Central nervous system infections are again 
lower than our results in studies from Nigeria v
and Sri Lanka 6 and are not mentioned in the 
English study ~. However, we believe that 
infections hould be one of the most common risk 
factors for epilepsy in developing countries. In 
Turkey it is still a major health problem, 
especially in the paediatric age group. We could 
not identify the aetiological factors of infections 
but cysticercosis, which is very common in most 
developing countries, is rarely encountered in 
Turkey because of nutritional habits of the 
Moslem religion. On the other hand none of our 
imaging studies revealed parasitic infections. 
Cerebro vascular diseases and brain tumours 
have almost similar figures in all studies men- 
tioned above, but alcohol abuse was remarkably 
high as a risk factor in the English study ~ 
compared with the others, reflecting the 
differences between an industrialized and de- 
veloping countries. One or more abnormalities 
could be demonstrated in 230 (56.7%) of the 531 
patients who underwent CT and 38 (49.3%) of 
the 75 patients who had MRI. 
In our study, 83% of patients were receiving 
monotherapy and 17% polytherapy. The most 
widely-used antiepileptic drug was found to be 
carbamazepine (CMZ) in our study. The second 
one was phenytoin (PHT) and the third was 
Maliasin ® (barbexaclone). Although phenobar- 
bital is the cheapest drug, as its prescription is 
restricted by laws it is no longer used very often. 
The high usage of CMZ may partly be explained 
by the high percentage ofpartial seizures, but the 
main reason seems to be physicians choice. A 
considerable number of our patients are followed 
by psychiatrists simultaneously therefore, from 
their point of view, CMZ helps behavioural 
problems too. On the other hand, although 
valproic acid (VA) is accepted as the drug of 
choice for most of the seizures its cost 
effectiveness limits its usage in Turkey. Vigabat- 
rin and Lamotrigine came on to the market very 
recently. 
The brand name of the drug barbexaclone, mentioned in this 
paper, is Maliasin ® (Knoll). It is composed of phenobarbitol 
(PHB) and 1-cycloheksidin 2-metil aminopropan (CHP). 
There are two types: 100mg (60mg PHB and 40mg CHP) 
and 25mg (15mg PHB and 10mg CHP). It is claimed to 
cause fewer side-effects than PHB alone. The drug is used 
in Turkey, Germany, Italy, Greece, etc. and it is cheaper than 
drugs containing carbamazepine or valproic acid. 
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We can conclude that our results more or less 
reflect a profile of Turkey because istanbul is a 
city where most of the residents have migrated 
from different parts of Turkey. However it is 
obvious that we need more detailed epidemiolog- 
ical studies for more reliable conclusions. 
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